Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 8/20 | 0.65 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | F13A1 | P00488 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6207183 | 0.98 | ACLY (0.63) | ACLYNAAAF13A1 | |
| SCHEMBL4778926 | 0.95 | ACLY (0.58) | ACLY | |
| Hydrochloric Acid SCHEMBL9083841 | 0.93 | ACLY (0.57) | ACLY | |
| SCHEMBL11037069 | 0.87 | ACLY (0.59) | ACLYNAAA | |
| SCHEMBL19612677 | 0.87 | ACLY (0.58) | ACLYNAAA | |
| SCHEMBL20672330 | 0.87 | F13A1 (0.56) | ACLYNAAAF13A1 | |
| SCHEMBL586345 | 0.86 | PDPK1 (0.59) | ACLY | |
| SCHEMBL30567601 | 0.86 | PDPK1 (0.59) | ACLY | |
| SCHEMBL11041035 | 0.85 | ACLY (0.56) | ACLYNAAA | |
| SCHEMBL11637870 | 0.85 | ACLY (0.56) | ACLYNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI HUI (TW) | 2020-05-19 | — | — | US | disclosed |
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI HUI (TW) | 2020-05-19 | — | — | US | disclosed |
| EP-2661440-B1 | METHOD FOR THE PREPARATION OF GLYCOSPHINGOLIPIDS | UNIV NAT TAIWAN (TW) | 2017-09-27 | — | — | EP | disclosed |
| EP-2661440-B1 | METHOD FOR THE PREPARATION OF GLYCOSPHINGOLIPIDS | UNIV NAT TAIWAN (TW) | 2017-09-27 | — | — | EP | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| EP-2661440-A2 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | National Taiwan University (TW) | 2013-11-13 | — | — | EP | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| WO-2012094540-A2 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | UGCG, CERS2, SGMS1 | ACLY 1280/4885NAAA 548/4885F13A1 679/4885 |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | UGCG, CERS2, SGMS1 | ACLY 1280/4885NAAA 548/4885F13A1 679/4885 |
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | UGCG, CERS2, SGMS1 | ACLY 1280/4885NAAA 548/4885F13A1 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.